5 Best Performing Healthcare ETFs in 2022

3. Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP)

YTD Return as of December 9: 0.66%

The Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) has gained 0.66% so far in 2022, as of December 9, and is ranked high among the best performing healthcare ETFs in 2022. The fund uses a full replication technique to track the returns of the LifeSci Biotechnology Products Index. The fund has an expense ratio of 0.79%.

The Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) has 54 holdings and a top ten holdings concentration of 29.34%. One of the fund’s most notable holdings is Biogen Inc. (NASDAQ:BIIB), which has gained 16.89% year to date as of December 9. On December 1, Atlantic Equities analyst Steve Chesney raised his price target on Biogen Inc. (NASDAQ:BIIB) to $295 from $220 and reiterated a Neutral rating on the shares.

As of September 30, Steven Cohen’s Point72 Asset Management is the largest shareholder in Biogen Inc. (NASDAQ:BIIB). The fund’s stakes are valued at $448 million.

Here is what ClearBridge Investments had to say about Biogen Inc. (NASDAQ:BIIB) in its third-quarter 2022 investor letter:

“Biogen Inc. (NASDAQ:BIIB) was the leading contributor among several biopharma names, boosted by positive, pivotal clinical data for its next-generation Alzheimer’s treatment Lecanemab. In a pivotal trial, the drug proved safe and efficacious in slowing progression of Alzheimer’s disease.”